{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:02:22Z","timestamp":1747454542402,"version":"3.40.5"},"reference-count":30,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>This review investigates that effective cancer treatment enhances the number of survivors in Denmark, but late complications like chemotherapy-induced peripheral neuropathy (CIPN) are a challenge. CIPN affects sensory nerves and can persist post-treatment. Diagnosis relies on symptoms and the medical history. Treatment options are limited and management faces geographic disparities and clinical capacity issues. Future research targets predictive markers and possible preventative interventions. CIPN, among other late complications, remains a significant concern in survivorship care.<\/jats:p>","DOI":"10.61409\/v05240318","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T13:26:26Z","timestamp":1730208386000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Chemotherapy-induced peripheral neuropathy among breast cancer survivors"],"prefix":"10.61409","author":[{"given":"Mie Collin Lund","family":"Sloth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Louise Aar\u00f8n\u00e6s","family":"Thybo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders Bonde","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Ventzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"ref0","unstructured":"Sundhedsdatastyrelsen. Nye kr\u00e6fttilf\u00e6lde i Danmark 2022, 2022. https:\/\/sundhedsdatastyrelsen.dk\/da\/find-tal-og-analyser\/tal-og-analyser\/sygdomme-og-behandlinger\/kraeft\/kraeft_nyetilfaelde_aarsrapport (09. sept 2024)"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Ventzel L, Jensen AB, Jensen AR et al. Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel. Pain. 2016;157(3):560-568. https:\/\/doi.org\/10.1097\/j.pain.0000000000000404","DOI":"10.1097\/j.pain.0000000000000404"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Bennedsgaard K, Ventzel L, Themistocleous AC et al. Long\u2010term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy. Cancer Med. 2020;9(14):5114-23. https:\/\/doi.org\/10.1002\/cam4.3129","DOI":"10.1002\/cam4.3129"},{"key":"ref3","unstructured":"Sundhedsstyrelsen. Vidensopsamling p\u00e5 senf\u00f8lger efter kr\u00e6ft hos voksne, 2017. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2017\/Vidensopsamling-p%C3%A5-senf%C3%B8lger-efter-kr%C3%A6ft-hos-voksne.ashx?sc_lang=da&hash=DAF12BA4D0B0D4273E45D2D5AD556337 (05. sep 2024)"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy\u2010induced peripheral neuropathy: a current review. Ann Neurol. 2017;81(6):772-81. https:\/\/doi.org\/10.1002\/ana.24951","DOI":"10.1002\/ana.24951"},{"key":"ref5","unstructured":"Lar\u00f8nningen S, Arvidsson G, Bray F et al. Danmark, Bryst, 2023. https:\/\/gco.iarc.fr\/media\/nordcan\/factsheets\/93\/dk\/countries\/208\/bryst-180-danmark-208.pdf. (09.sept 2024)"},{"key":"ref6","unstructured":"Knop AS, Tvedskov THF, S\u00f8ndergaard A et al. Brystkr\u00e6ft, 2024. https:\/\/www.sundhed.dk\/sundhedsfaglig\/laegehaandbogen\/brystsygdomme\/tilstande-og-sygdomme\/kvinder\/brystkraeft\/ (05. sep 2024)"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Molinares D, Kurtevski S, Zhu Y. Chemotherapy-induced peripheral neuropathy: diagnosis, agents, general clinical presentation, and treatments. Curr Oncol Rep. 2023;25(11):1127-1235. https:\/\/doi.org\/10.1007\/s11912-023-01449-7","DOI":"10.1007\/s11912-023-01449-7"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zaj\u0105czkowska R, Kocot-K\u0119pska M, Leppert W et al. Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2019;20(6):1451. https:\/\/doi.org\/10.3390\/ijms20061451","DOI":"10.3390\/ijms20061451"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Desforges AD, Hebert CM, Spence AL et al. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update. Biomed Pharmacother. 2022;147:112671. https:\/\/doi.org\/10.1016\/j.biopha.2022.112671","DOI":"10.1016\/j.biopha.2022.112671"},{"key":"ref10","unstructured":"Christensen J, Kristensen J. Perifer neuropati. sundhed.dk: L\u00e6geh\u00e5ndbogen; 2023. https:\/\/www.sundhed.dk\/sundhedsfaglig\/laegehaandbogen\/neurologi\/tilstande-og-sygdomme\/neuropatier\/perifer-neuropati\/ (09. sept 2024)"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Terkelsen AJ, Karlsson P, Lauria G et al. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol. 2017;16(11):934-44. https:\/\/doi.org\/10.1016\/S1474-4422(17)30329-0","DOI":"10.1016\/S1474-4422(17)30329-0"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Herman WH, Pop-Busui R, Braffett BH et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications. Diabet Med. 2012;29(7):937-44. https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03644.x","DOI":"10.1111\/j.1464-5491.2012.03644.x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Bouhassira D, Attal N, Alchaar H et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36. https:\/\/doi.org\/10.1016\/j.pain.2004.12.010","DOI":"10.1016\/j.pain.2004.12.010"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol. 2020;38(28):3325-3348. https:\/\/doi.org\/10.1200\/JCO.20.01399","DOI":"10.1200\/JCO.20.01399"},{"key":"ref15","unstructured":"Friderichsen BWA, Jensen AN, Ibsen HS, Nielsen MK. Kr\u00e6ftopf\u00f8lgning i almen praksis, 2019. https:\/\/www.dsam.dk\/vejledninger\/cancer\/8-senfolger#fysiske-senfoelger (09. sept 2024)"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Jordan B, Margulies A, Cardoso F et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306-1319. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.003","DOI":"10.1016\/j.annonc.2020.07.003"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"D'Souza RS, Alvarez GAM, Dombovy-Johnson M et al. Evidence-based treatment of pain in chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep. 2023;27(5):99-116. https:\/\/doi.org\/10.1007\/s11916-023-01107-4","DOI":"10.1007\/s11916-023-01107-4"},{"key":"ref18","unstructured":"Kr\u00e6ft i Danmark 2022. K\u00f8benhavn: Kr\u00e6ftens Bek\u00e6mpelse; 2022. https:\/\/www.cancer.dk\/om-os\/udgivelser-og-rapporter\/viden-om-kraeft\/2022-kraeft-i-danmark-2022\/ (09. sept 2024)"},{"key":"ref19","unstructured":"Kr\u00e6ftens Bek\u00e6mpelse. Senf\u00f8lgeklinikker, 2023. https:\/\/www.cancer.dk\/hverdag\/senfoelger\/senfoelgeklinikker\/ (09. sept 2024)"},{"key":"ref20","unstructured":"National R\u00e5dgivningsenhed for Brystkr\u00e6ftsenf\u00f8lger. brystkraeftsenfoelger.dk: Center & Clinic for Late Effects https:\/\/brystkraeftsenfoelger.dk\/nationaleraadgivningsenhed\/ (09. sept 2024)"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Cavaletti G, Pizzamiglio C, Man A et al. Studies to assess the utility of serum neurofilament light chain as a biomarker in chemotherapy-induced peripheral neuropathy. Cancers (Basel). 2023;15(17):4216. https:\/\/doi.org\/10.3390\/cancers15174216","DOI":"10.3390\/cancers15174216"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Mortensen C, Steffensen KD, Simonsen E et al. Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer. Pain. 2023;164:1502-1511. https:\/\/doi.org\/10.1097\/j.pain.0000000000002840","DOI":"10.1097\/j.pain.0000000000002840"},{"key":"ref23","unstructured":"Parkner T. Analysedetaljer: P-Neurofilament light polypeptide, 2024. https:\/\/www.analysefortegnelsen.dk\/AnalyselisteZoom.asp?Type=&Lok=HEM&Id=NPU57704 (12. jun 2024)"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Chow R, Novosel M, So OW et al. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. BMJ Support Palliat Care. 2023;13(1):27-34. https:\/\/doi.org\/10.1136\/spcare-2022-003815","DOI":"10.1136\/spcare-2022-003815"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Lopez-Garzon M, Cantarero-Villanueva I, Postigo-Martin P et al. Can physical exercise prevent chemotherapy-induced peripheral neuropathy in patients with cancer? Arch Phys Med Rehabil. 2022;103(11):2197-2208. https:\/\/doi.org\/10.1016\/j.apmr.2022.02.008","DOI":"10.1016\/j.apmr.2022.02.008"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Brownson-Smith R, Orange ST, Cresti N et al. Effect of exercise before and\/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis. J Cancer Surviv. 2023. https:\/\/doi.org\/10.1007\/s11764-023-01450-w","DOI":"10.1007\/s11764-023-01450-w"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Klafke N, Bossert J, Kr\u00f6ger B et al. Prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN) with non-pharmacological interventions: clinical recommendations from a systematic scoping review and an expert consensus process. Med Sci (Basel). 2023;11(1):15. https:\/\/doi.org\/10.3390\/medsci11010015","DOI":"10.3390\/medsci11010015"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Papadopoulou M, Stamou M, Bakalidou D et al. Non-pharmacological interventions on pain and quality of life in chemotherapy induced polyneuropathy: systematic review and meta-analysis. In Vivo. 2023;37(1):47-56. https:\/\/doi.org\/10.21873\/invivo.13053","DOI":"10.21873\/invivo.13053"},{"key":"ref29","unstructured":"Kr\u00e6ftens Bek\u00e6mplse. Fors\u00f8gets titel:CryoPac, 2021 https:\/\/forsoeg.cancer.dk\/924466\/ (09. sept 2024)"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:15:54Z","timestamp":1747376154000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V05240318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":30,"URL":"https:\/\/doi.org\/10.61409\/v05240318","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2024,10,7]]}}}